Neuroprotective Effects of GDNF-expressing Human Amniotic Fluid Cells

[1]  Hung-Chuan Pan.  Retraction: Enhancement of regeneration with glia cell line-derived neurotrophic factor-transduced human amniotic fluid mesenchymal stem cells after sciatic nerve crush injury. , 2015, Journal of neurosurgery.

[2]  D. Fauza,et al.  Intra-Amniotic Delivery of Amniotic-Derived Neural Stem Cells in a Syngeneic Model of Spina Bifida , 2013, Fetal Diagnosis and Therapy.

[3]  S. Gill,et al.  Clearance and Toxicity of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHu GDNF) Following Acute Convection-Enhanced Delivery into the Striatum , 2013, PloS one.

[4]  Yu-Qin Hu,et al.  Neural Stem-Like Cells Derived from Human Amnion Tissue are Effective in Treating Traumatic Brain Injury in Rat , 2013, Neurochemical Research.

[5]  C. Duarte,et al.  Neuroprotection by GDNF in the ischemic brain , 2012, Growth factors.

[6]  G. Remuzzi,et al.  Human amniotic fluid stem cell preconditioning improves their regenerative potential. , 2012, Stem cells and development.

[7]  R. Cancedda,et al.  Erratum to “Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model” [Biomaterials 32 (2011) 3689–3699] , 2012 .

[8]  M. Sikorska,et al.  Human Amniotic Fluid Cells Form Functional Gap Junctions with Cortical Cells , 2012, Stem cells international.

[9]  M. Sikorska,et al.  Development of BMP7-producing human cells, using a third generation lentiviral gene delivery system , 2012, Journal of Neuroscience Methods.

[10]  P. Ferretti,et al.  Amniotic fluid stem cells increase embryo survival following injury. , 2012, Stem cells and development.

[11]  A. Atala,et al.  Amniotic fluid-derived stem cells in regenerative medicine research , 2012, Archives of pharmacal research.

[12]  M. Morbidelli,et al.  Longitudinal Tracking of Human Fetal Cells Labeled with Super Paramagnetic Iron Oxide Nanoparticles in the Brain of Mice with Motor Neuron Disease , 2012, PloS one.

[13]  Z. Fei,et al.  VEGF protects rat cortical neurons from mechanical trauma injury induced apoptosis via the MEK/ERK pathway , 2011, Brain Research Bulletin.

[14]  S. Chrapusta,et al.  Long-term consequences of surgical brain injury - characteristics of the neurovascular unit and formation and demise of the glial scar in a rat model. , 2011, Folia neuropathologica.

[15]  B. Groner,et al.  The potential of amniotic fluid stem cells for cellular therapy and tissue engineering , 2011, Expert opinion on biological therapy.

[16]  R. Cancedda,et al.  Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model. , 2011, Biomaterials.

[17]  Li-Lin Tay,et al.  Detection of acute brain injury by Raman spectral signature. , 2011, The Analyst.

[18]  D. Miao,et al.  Transplanted Human Amniotic Membrane-Derived Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Cirrhosis in Mouse , 2011, PloS one.

[19]  N. Tajiri,et al.  Intravenous infusion of GDNF gene-modified human umbilical cord blood CD34+ cells protects against cerebral ischemic injury in spontaneously hypertensive rats , 2010, Brain Research.

[20]  Seung U. Kim,et al.  Human neural stem cells genetically modified to overexpress brain‐derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model , 2010, Journal of neuroscience research.

[21]  K. Abe,et al.  Antiapoptotic and antiautophagic effects of glial cell line‐derived neurotrophic factor and hepatocyte growth factor after transient middle cerebral artery occlusion in rats , 2010, Journal of neuroscience research.

[22]  Y. Sekino,et al.  Interleukin‐6‐type cytokines in neuroprotection and neuromodulation: oncostatin M, but not leukemia inhibitory factor, requires neuronal adenosine A1 receptor function , 2010, Journal of neurochemistry.

[23]  J. Moon,et al.  Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells. , 2010, Stem cells and development.

[24]  E. Williams,et al.  Transplantation of Human Amnion Epithelial Cells Reduces Hepatic Fibrosis in Immunocompetent CCl4-Treated Mice , 2010, Cell transplantation.

[25]  Dar-Yu Yang,et al.  Enhancement of regeneration with glia cell line-derived neurotrophic factor-transduced human amniotic fluid mesenchymal stem cells after sciatic nerve crush injury. , 2010, Journal of neurosurgery.

[26]  H. Haider,et al.  Preconditioning and Stem Cell Survival , 2010, Journal of cardiovascular translational research.

[27]  M. Sikorska,et al.  Probing Stemness and Neural Commitment in Human Amniotic Fluid Cells , 2010, Stem Cell Reviews and Reports.

[28]  Sing Yian Chew,et al.  The application of nanofibrous scaffolds in neural tissue engineering. , 2009, Advanced drug delivery reviews.

[29]  Jingli Cai,et al.  Human amniotic fluid stem cells do not differentiate into dopamine neurons in vitro or after transplantation in vivo. , 2009, Stem cells and development.

[30]  V. Berezin,et al.  Role of Glial Cell Line-Derived Neurotrophic Factor (GDNF)–Neural Cell Adhesion Molecule (NCAM) Interactions in Induction of Neurite Outgrowth and Identification of a Binding Site for NCAM in the Heel Region of GDNF , 2009, The Journal of Neuroscience.

[31]  K. Zhang,et al.  Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats , 2009, Brain Research.

[32]  L. Cerchia,et al.  GDNF Selectively Induces Microglial Activation and Neuronal Survival in CA1/CA3 Hippocampal Regions Exposed to NMDA Insult through Ret/ERK Signalling , 2009, PloS one.

[33]  K. Aroom,et al.  Advances in Progenitor Cell Therapy Using Scaffolding Constructs for Central Nervous System Injury , 2009, Stem Cell Reviews and Reports.

[34]  C. Verfaillie,et al.  Stem cells for ischemic brain injury: A critical review , 2009, The Journal of comparative neurology.

[35]  D. Schmidt,et al.  Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? , 2009, Regenerative medicine.

[36]  M. Sikorska,et al.  Neuroregenerative strategies in the brain: emerging significance of bone morphogenetic protein 7 (BMP7). , 2008, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[37]  P. Grieb,et al.  Apoptotic death of cortical neurons following surgical brain injury. , 2008, Folia neuropathologica.

[38]  R. Bellamkonda,et al.  Biomaterials for the central nervous system , 2008, Journal of The Royal Society Interface.

[39]  Y. Durocher,et al.  Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  Hung Li,et al.  Stromal Cell-Derived Factor-1α Promotes Neuroprotection, Angiogenesis, and Mobilization/Homing of Bone Marrow-Derived Cells in Stroke Rats , 2008, Journal of Pharmacology and Experimental Therapeutics.

[41]  David G Simpson,et al.  Nanofiber technology: designing the next generation of tissue engineering scaffolds. , 2007, Advanced drug delivery reviews.

[42]  S. Ho,et al.  Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells , 2007, Journal of Clinical Neuroscience.

[43]  G. Biella,et al.  Differentiating embryonic stem–derived neural stem cells show a maturation-dependent pattern of voltage-gated sodium current expression and graded action potentials , 2007, Neuroscience.

[44]  Nirmal Singh,et al.  Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice , 2007, Behavioural Brain Research.

[45]  Zhihua Jiang,et al.  HUMAN AMNIOTIC EPITHELIAL CELLS AMELIORATE BEHAVIORAL DYSFUNCTION AND REDUCE INFARCT SIZE IN THE RAT MIDDLE CEREBRAL ARTERY OCCLUSION MODEL , 2007, Shock.

[46]  T. Matsui,et al.  Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia , 2007, The European journal of neuroscience.

[47]  G. Zucconi,et al.  Mesenchymal cells from human amniotic fluid survive and migrate after transplantation into adult rat brain , 2007, Cell biology international.

[48]  I. Moppett,et al.  Traumatic brain injury: assessment, resuscitation and early management. , 2007, British journal of anaesthesia.

[49]  Anthony Atala,et al.  Isolation of amniotic stem cell lines with potential for therapy , 2007, Nature Biotechnology.

[50]  W. Cass,et al.  GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease , 2007, Neuroscience Letters.

[51]  Yi Ai,et al.  Point source concentration of GDNF may explain failure of phase II clinical trial , 2006, Experimental Neurology.

[52]  K. Houkin,et al.  Intravenous administration of glial cell line‐derived neurotrophic factor gene‐modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat , 2006, Journal of neuroscience research.

[53]  B. Schlosshauer,et al.  Synthetic Nerve Guide Implants in Humans: A Comprehensive Survey , 2006, Neurosurgery.

[54]  Donald S. Prough,et al.  Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury , 2006, Experimental Neurology.

[55]  P. Walker,et al.  Role of Sox2 in the development of the mouse neocortex. , 2006, Developmental biology.

[56]  Dar-Yu Yang,et al.  Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell , 2006, Journal of Clinical Neuroscience.

[57]  T. Wieloch,et al.  Mechanisms of neural plasticity following brain injury , 2006, Current Opinion in Neurobiology.

[58]  E. Snyder,et al.  Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury , 2006, The European journal of neuroscience.

[59]  Mark Stacy,et al.  Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease , 2006, Annals of neurology.

[60]  R. Weisel,et al.  Increasing transplanted cell survival with cell-based angiogenic gene therapy. , 2005, The Annals of thoracic surgery.

[61]  S. Gill,et al.  Intraputamenal infusion of glial cell line–derived neurotrophic factor in PD: A two‐year outcome study , 2005, Annals of neurology.

[62]  Charles Tator,et al.  Endogenous and exogenous CNS derived stem/progenitor cell approaches for neurotrauma. , 2005, Current drug targets.

[63]  J. Trojanowski,et al.  A review and rationale for the use of cellular transplantation as a therapeutic strategy for traumatic brain injury. , 2004, Journal of neurotrauma.

[64]  R. Bauer,et al.  Potential stem cell therapy and application in neurotrauma. , 2004, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[65]  R. Slack,et al.  Emerging Role for ERK as a Key Regulator of Neuronal Apoptosis , 2004, Science's STKE.

[66]  C. Woolf,et al.  Adult neuron survival strategies — slamming on the brakes , 2004, Nature Reviews Neuroscience.

[67]  B. Yard,et al.  Preconditioning Strategies to Limit Graft Immunogenicity and Cold Ischemic Organ Injury , 2004, Journal of Investigative Medicine.

[68]  A. Björklund,et al.  Localized striatal delivery of GDNF as a treatment for Parkinson disease , 2004, Nature Neuroscience.

[69]  T. Ikeda,et al.  Grafting of glial cell line-derived neurotrophic factor secreting cells for hypoxic-ischemic encephalopathy in neonatal rats. , 2003, American journal of obstetrics and gynecology.

[70]  R. Dempsey,et al.  Stroke‐induced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF‐1 and GDNF , 2003, Journal of neurochemistry.

[71]  H. Federoff,et al.  HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury , 2003, Experimental Neurology.

[72]  P. Clarke,et al.  Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK , 2003, Nature Cell Biology.

[73]  A. Hebb,et al.  Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage. , 2003, Neurosurgical focus.

[74]  R. Muthusamy,et al.  Role of human amniotic epithelial cell transplantation in spinal cord injury repair research , 2003, Neuroscience.

[75]  W. Pan,et al.  Glial cell line-derived neurotrophic factor does not enter normal mouse brain , 2003, Neuroscience Letters.

[76]  M. Shoji,et al.  Protection against ischemic brain damage by GDNF affecting cell survival and death signals , 2003, Neurological research.

[77]  D. Brooks,et al.  Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease , 2003, Nature Medicine.

[78]  J. Jankovic,et al.  Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD , 2003, Neurology.

[79]  Yang D. Teng,et al.  The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue , 2002, Nature Biotechnology.

[80]  Y. Tsao,et al.  Gene therapy for treatment of cerebral ischemia using defective recombinant adeno-associated virus vectors. , 2002, Methods.

[81]  S. Kügler,et al.  Dose‐dependent rescue of axotomized rat retinal ganglion cells by adenovirus‐mediated expression of glial cell‐line derived neurotrophic factorin vivo , 2002, The European journal of neuroscience.

[82]  S. Kügler,et al.  Adenovirus-Mediated Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression Protects against Subsequent Cortical Cold Injury in Rats , 2001, Neurobiology of Disease.

[83]  D. Fauza,et al.  The amniotic fluid as a source of cells for fetal tissue engineering. , 2001, Journal of pediatric surgery.

[84]  M. Herman,et al.  GDNF Protects against Aluminum-Induced Apoptosis in Rabbits by Upregulating Bcl-2 and Bcl-XL and Inhibiting Mitochondrial Bax Translocation , 2001, Neurobiology of Disease.

[85]  S. Kügler,et al.  Adenovirus-Mediated GDNF and CNTF Pretreatment Protects against Striatal Injury Following Transient Middle Cerebral Artery Occlusion in Mice , 2001, Neurobiology of Disease.

[86]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[87]  Takeshi Hayashi,et al.  Time dependent amelioration against ischemic brain damage by glial cell line-derived neurotrophic factor after transient middle cerebral artery occlusion in rat , 2001, Brain Research.

[88]  E. Mackenzie,et al.  Neuroprotection Mediated by Glial Cell Line-Derived Neurotrophic Factor: Involvement of a Reduction of NMDA-Induced Calcium Influx by the Mitogen-Activated Protein Kinase Pathway , 2001, The Journal of Neuroscience.

[89]  K. Abe,et al.  Gene therapy with adenovirus-mediated glial cell line-derived neurotrophic factor and neural stem cells activation after ischemic brain injury. , 2001, Human cell.

[90]  Shinn-Zong Lin,et al.  Recombinant Adeno-Associated Virus Vector Expressing Glial Cell Line-Derived Neurotrophic Factor Reduces Ischemia-Induced Damage , 2000, Experimental Neurology.

[91]  K. Abe.  Therapeutic Potential of Neurotrophic Factors and Neural Stem Cells Against Ischemic Brain Injury , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[92]  A. Björklund,et al.  Cell replacement therapies for central nervous system disorders , 2000, Nature Neuroscience.

[93]  Y. Mitsumoto,et al.  Adenovirus-Mediated Gene Transfer of Glial Cell Line-Derived Neurotrophic Factor Prevents Ischemic Brain Injury after Transient Middle Cerebral Artery Occlusion in Rats , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[94]  B. Hoffer,et al.  Glial cell line-derived neurotrophic factor receptor α1 availability regulates glial cell line-derived neurotrophic factor signaling: evidence from mice carrying one or two mutated alleles , 1999, Neuroscience.

[95]  M. Hong,et al.  Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells , 1998, Neuroscience.

[96]  D J Mooney,et al.  Development of biocompatible synthetic extracellular matrices for tissue engineering. , 1998, Trends in biotechnology.

[97]  Y. Itoyama,et al.  Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. , 1998, Stroke.

[98]  V. Mehta,et al.  Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor. , 1998, Journal of neurosurgery.

[99]  P. Koeberle,et al.  Effects of GDNF on retinal ganglion cell survival following axotomy , 1998, Vision Research.

[100]  E. Clarkson,et al.  Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats , 1998, Brain Research.

[101]  A. Granholm,et al.  Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum , 1997, Experimental Brain Research.

[102]  Y. Itoyama,et al.  Amelioration of brain edema by topical application of glial cell line-derived neurotrophic factor in reperfused rat brain , 1997, Neuroscience Letters.

[103]  E. Clarkson,et al.  GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro , 1997, Cell and Tissue Research.

[104]  B. Hoffer,et al.  Glial Cell Line-Derived Neurotrophic Factor Protects against Ischemia-Induced Injury in the Cerebral Cortex , 1997, The Journal of Neuroscience.

[105]  A. Buj-Bello,et al.  Characterization of a multicomponent receptor for GDNF , 1996, Nature.

[106]  J. Wrathall,et al.  Neurotrophic factors in central nervous system trauma. , 1995, Journal of neurotrauma.

[107]  R. Oppenheim,et al.  Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF , 1995, Nature.

[108]  C. Cotman,et al.  Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons , 1994, Neuroreport.

[109]  F. Gage,et al.  Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitro , 1985, Neuroscience Letters.

[110]  S. Leibowitz,et al.  IMMUNOGENICITY OF HUMAN AMNIOTIC EPITHELIAL CELLS AFTER TRANSPLANTATION INTO VOLUNTEERS , 1981, The Lancet.

[111]  D. Roberts,et al.  The quantitative measurement of motor inco‐ordination in naive mice using an accelerating rotarod , 1968 .

[112]  K. Soderstrom,et al.  Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects cortical neurons from dying following a traumatic brain injury. , 2010, Restorative neurology and neuroscience.

[113]  Z. Karabekian,et al.  Stem Cell Rev and Rep , 2010 .

[114]  L. Tătăranu,et al.  NEUROPROTECTION AGAINST SURGICALLY INDUCED BRAIN INJURY , 2009 .

[115]  D. Fauza,et al.  Autologous Approaches to Tissue Engineering , 2008 .

[116]  A. Atala,et al.  Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. , 2007, The Journal of urology.

[117]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[118]  S. Doré,et al.  Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway. , 2000, Journal of neural transmission. Supplementum.

[119]  R M Nerem,et al.  Tissue engineering: from biology to biological substitutes. , 1995, Tissue engineering.

[120]  B. Pike,et al.  The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. , 1994, Journal of neurotrauma.

[121]  D. Roberts,et al.  The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod. , 1968, The Journal of pharmacy and pharmacology.